| Product Name | MF | CAS | Details |
|---|
| Anti-PCSK9 Reference Antibody (ralpancizumab) | Details |
| Anti-PCSK9 Reference Antibody (recaticimab) | Details |
| Anti-PCSK9 Reference Antibody (RG7652) | Details |
| Anti-PCSK9 Reference Antibody (Schering patent anti-PCSK9) | Details |
| Anti-PCSK9 Reference Antibody (tafolecimab) | Details |
| Anti-PDCD1 / PD-1 / CD279 Reference Antibody (balstilimab) | Details |
| Anti-PDCD1 / PD-1 / CD279 Reference Antibody (budigalimab) | Details |
| Anti-PDCD1 / PD-1 / CD279 Reference Antibody (camrelizumab) | Details |
| Anti-PDCD1 / PD-1 / CD279 Reference Antibody (cetrelimab) | Details |
| Anti-PDCD1 / PD-1 / CD279 Reference Antibody (dostarlimab) | Details |
| Anti-PDCD1 / PD-1 / CD279 Reference Antibody (ezabenlimab) | Details |
| Anti-PDCD1 / PD-1 / CD279 Reference Antibody (finotonlimab) | Details |
| Anti-PDCD1 / PD-1 / CD279 Reference Antibody (geptanolimab) | Details |
| Anti-PDCD1 / PD-1 / CD279 Reference Antibody (iparomlimab) | Details |
| Anti-PDCD1 / PD-1 / CD279 Reference Antibody (nivolumab) | Details |
| Anti-PDCD1 / PD-1 / CD279 Reference Antibody (nofazinlimab) | Details |
| Anti-PDCD1 / PD-1 / CD279 Reference Antibody (pembrolizumab) | Details |
| Anti-PDCD1 / PD-1 / CD279 Reference Antibody (penpulimab) | Details |
| Anti-PDCD1 / PD-1 / CD279 Reference Antibody (pidilizumab) | Details |
| Anti-PDCD1 / PD-1 / CD279 Reference Antibody (pimivalimab) | Details |
| Anti-PDCD1 / PD-1 / CD279 Reference Antibody (prolgolimab) | Details |
| Anti-PDCD1 / PD-1 / CD279 Reference Antibody (retifanlimab) | Details |
| Anti-PDCD1 / PD-1 / CD279 Reference Antibody (sasanlimab) | Details |
| Anti-PDCD1 / PD-1 / CD279 Reference Antibody (serplulimab) | Details |
| Anti-PDCD1 / PD-1 / CD279 Reference Antibody (sintilimab) | Details |
| Anti-PDCD1 / PD-1 / CD279 Reference Antibody (spartalizumab) | Details |
| Anti-PDCD1 / PD-1 / CD279 Reference Antibody (tislelizumab) | Details |
| Anti-PDCD1 / PD-1 / CD279 Reference Antibody (toripalimab) | Details |
| Anti-PDCD1 / PD-1 / CD279 Reference Antibody (UCB patent anti-PD-1) | Details |
| Anti-PDCD1 / PD-1 / CD279 Reference Antibody (zimberelimab) | Details |
| Anti-PDGFB Reference Antibody (MOR-8457) | Details |
| Anti-PDGFC / VEGFE Reference Antibody (Thrombogenics patent anti-PDGF-C) | Details |
| Anti-PDGFRA / CD140a Reference Antibody (olaratumab) | Details |
| Anti-PDGFRA / CD140a Reference Antibody (tovetumab) | Details |
| Anti-PGLYRP1 / PGRP-S Reference Antibody (Novo Nordisk patent anti-PGLYRP1) | Details |
| Anti-Phosphatidylserine Reference Antibody (bavituximab) | Details |
| Anti-Phosphorylcholine Reference Antibody (ATH3G10) | Details |
| Anti-PLA2G1B Reference Antibody (Diaccurate patent anti-sPLA2-GIB) | Details |
| Anti-PLAUR / uPAR / CD87 Reference Antibody (ATN-658) | Details |
| Anti-PMEL Reference Antibody (Genentech anti-PMEL17) | Details |
| Anti-PMEL Reference Antibody (Novartis patent anti-PMEL17) | Details |
| Anti-Polyubiquitin Reference Antibody (Genentech patent anti-Polyubiquitin) | Details |
| Anti-PRAME Reference Antibody (Eureka patent anti-PRAME) | Details |
| Anti-PRLR / Prolactin Receptor Reference Antibody (BAY 1158061) | Details |
| Anti-PRLR / Prolactin Receptor Reference Antibody (rolinsatamab) | Details |
| Anti-PROM1 / CD133 Reference Antibody (Forerunner patent anti-Prominin-1) | Details |
| Anti-PSCA Reference Antibody (AGS-1C4D4) | Details |
| Anti-P-Selectin / CD62p Reference Antibody (crizanlizumab) | Details |
| Anti-P-Selectin / CD62p Reference Antibody (inclacumab) | Details |
| Anti-PSGL1 / CD162 Reference Antibody (neihulizumab) | Details |
| Anti-PTK7 / CCK4 Reference Antibody (cofetuzumab) | Details |
| Anti-PTPRC / CD45 Reference Antibody (apamistamab) | Details |
| Anti-PTPRC / CD45 Reference Antibody (Novartis patent anti-CD45) | Details |
| Anti-PVRIG Reference Antibody (COM701) | Details |
| Anti-PVRIG Reference Antibody (GSK4381562) | Details |
| Anti-RAMP3 Reference Antibody (Medella patent anti-RAMP-3) | Details |
| Anti-PDGFRB / CD140b Reference Antibody (IMC-2C5) | Details |
| Anti-PDGFRB / CD140b Reference Antibody (rinucumab) | Details |
| Anti-RTN4 / NOGO Reference Antibody (NG-101) | Details |
| Anti-RTN4 / NOGO Reference Antibody (ozanezumab) | Details |
| Anti-S100A4 Reference Antibody (LK-1) | Details |
| Anti-SARS Reference Antibody (80R ) | Details |
| Anti-SCFR / c-Kit / CD117 Reference Antibody (CDX-0158) | Details |
| Anti-SCFR / c-Kit / CD117 Reference Antibody (LOP628) | Details |
| Anti-SCN11a / Nav1.9 Reference Antibody (Wuhan U. patent anti-Nav1.9) | Details |
| Anti-SCN9a / Nav1.7 Reference Antibody (Duke anti-NAv1.7) | Details |
| Anti-SEMA4D / CD100 Reference Antibody (pepinemab) | Details |
| Anti-SERPINE1 Reference Antibody (Sanofi patent anti-PAI-1) | Details |
| Anti-Serum Amyloid P / SAP Reference Antibody (dezamizumab) | Details |
| Anti-Sialyl-Lewis A Reference Antibody (MVT-5873) | Details |
| Anti-Siglec-15 / CD33L3 Reference Antibody (AB-25E9) | Details |
| Anti-RGMC / HFE2 Reference Antibody (DISC-0974) | Details |
| Anti-RSPO3 Reference Antibody (rosmantuzumab) | Details |
| Anti-Siglec-15 / CD33L3 Reference Antibody (Medimmune patent anti-Siglec-15) | Details |
| Anti-Siglec-2 / CD22 Reference Antibody (NCI m972) | Details |
| Anti-SIRPA / CD172a Reference Antibody (Hospital for Sick Children patent anti-SIRPA) | Details |
| Anti-SLAMF7 / CS1 Reference Antibody (PDL241) | Details |
| Anti-ROR1 Reference Antibody (zilovertamab) | Details |
| Anti-Siglec-2 / CD22 Reference Antibody (NCI m971) | Details |
| Anti-Siglec-3 / CD33 Reference Antibody (vadastuximab) | Details |
| Anti-RHD / CD240d Reference Antibody (LFB Anti-RhD) | Details |
| Anti-RTN4 / NOGO Reference Antibody (atinumab) | Details |
| Anti-Siglec-15 / CD33L3 Reference Antibody (NC318) | Details |
| Anti-Siglec-2 / CD22 Reference Antibody (pinatuzumab) | Details |
| Anti-RG1 Reference Antibody (19G9) | Details |
| Anti-SIRPa Reference Antibody (KWAR23) | Details |
| Anti-SLC1A5 / ASCT2 Reference Antibody (idactamab) | Details |
| Anti-RSPO1 Reference Antibody (Oncomed patent anti-RSPO1) | Details |
| Anti-Siglec-4a / MAG Reference Antibody (refanezumab) | Details |
| Anti-SLAMF7 / CS1 Reference Antibody (azintuxizumAb) | Details |
| Anti-RHD / CD240d Reference Antibody (roledumab) | Details |
| Anti-Siglec-2 / CD22 Reference Antibody (epratuzumab) | Details |
| Anti-Siglec-3 / CD33 Reference Antibody (IMGN779) | Details |
| Anti-RGMA Reference Antibody (elezanumab) | Details |
| Anti-SLAMF6 / CD352 Reference Antibody (SGN-CD352A) | Details |
| Anti-Siglec-8 Reference Antibody (lirentelimab) | Details |
| Anti-SLAMF7 / CS1 Reference Antibody (elotuzumab) | Details |
| Anti-ROBO1 Reference Antibody (Asclepius Technology patent anti-Robo1 CAR) | Details |
| Anti-Siglec-2 / CD22 Reference Antibody (inotuzumab) | Details |
| Anti-Siglec-3 / CD33 Reference Antibody (lintuzumAb) | Details |
| Product Total： Product Page： | ||||
| 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 | ||||